ABIOMED Inc (ABMD)

328.52
+4.98(+1.54%)
After Hours
328.52
0.00(0.00%)
- Real-time Data
  • Volume:
    148,018
  • Bid/Ask:
    290.00/350.00
  • Day's Range:
    323.84 - 328.84

ABMD Overview

Prev. Close
323.54
Day's Range
323.84-328.84
Revenue
847.52M
Open
327.44
52 wk Range
242.73-387.4
EPS
4.94
Volume
148,018
Market Cap
14.9B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
259,051
P/E Ratio
66.53
Beta
1.3
1-Year Change
-72.66%
Shares Outstanding
45,344,956
Next Earnings Date
Nov 04, 2021
What is your sentiment on ABIOMED Inc?
or
Market is currently closed. Voting is open during market hours.

ABIOMED Inc News

ABIOMED Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy

ABIOMED Inc Company Profile

ABIOMED Inc Company Profile

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the Automated Impella Controller for physicians and hospital staffs; and OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; and Impella BTR, a percutaneous micro heart pump with integrated motors and sensors. Abiomed, Inc. sells its products through direct sales and clinical support personnel in the United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.

Read More
  • Under 170.00
    3
    • post your reasons.
      0
  • what just happened?! this popped 10% today
    0
    • Guys what is wrong with this stock?
      0
      • Good time to collect
        3
        • When?
          1
      • ok so whats happening again
        1
        • Good time to collect
          1
      • I think so ..it's undervalued
        0
        • DO YOU think ti will rise to 250 usd ? soon or very late ?
          2
          • No will drop to $155
            3
        • a report suggested that impella product from abmd is no good.
          1
          • anyone knows why the drastic drop?
            0
            • curious either on why?
              0
            • a report suggested that impella product from abmd is no good.
              0
          • Shortcovering will start at 220 area. I mean heavy shortcovering.
            0
            • Will try 250 first then march for 275 area,
              0
              • Any thoughts on this one? Could be good upside
                0
                • What a movement today! fell 19% and recovered fully. Both shorts and longs might have got trapped. But why did it fall. the results are good. from here upmove only
                  0
                  • what was it?
                    0
                    • what the... what happened here??
                      0
                  • Wait, Abimed will surge soon!!!!
                    0
                    • chart is not moving!
                      0
                      • Products and demand are there for Abiomed. Bought at 315 yesterday sold 333 today. Huge profit! Abiomed is a solid company so 10-31's financial report may prove you wrong?
                        0
                        • this sudden drop was very suspicious!! . This stock is broken now
                          1
                          • Another Great buying time. This stock will quit the yoyo soon and stay 475+. Once it breaks 500 then there's no turning back. Solid company - solid products.
                            1
                            • People this is a very profitable company with a great line of products. Stock is ready to ride up again. $500 + coming! Stayng Very Bullish.
                              0
                              • Smart play: Rode it up to new high & sold. After huge fall I rode it back up. Now will do it again! Huge profits! Finally figured it out.
                                1
                                • This is a great company and products. This stock should go $500 plus soon.
                                  0
                                  • The stock was moving back to firmer highs! Why the selloff?
                                    0
                                    • What happened? Why such a drop?
                                      0
                                      • Short term nervous people but the report was outstanding. .78 or share vs .82 projected. I bought more today!
                                        0
                                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.